@thrasher. I ama substantiatal holder and I think remuneration especially bonuses and share package for so little SHV is disgrace and management have shown are incompetent at commercialising products properly for many years. Only good deal is AstraZeneca about 6 years ago. The trials take too long and the data is not properly provided just selecting best aspects. Continuous disclose is ignored. No jealousy here.
Ann: SPL7013 in VIRALEZE virucidal against influenza A and B, page-39
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |